4.5 Article

Effects of the Multicomponent Cognitive Training Program BrainProtect in Cognitively Healthy Adults: A Randomized Controlled Trial

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 94, 期 3, 页码 1013-1034

出版社

IOS PRESS
DOI: 10.3233/JAD-220619

关键词

Alzheimer's disease; cognitive integrity; cognitive training; healthy aging; prevention

向作者/读者索取更多资源

This study compared the short-term effects of multicomponent cognitive training with general health counseling on cognitive abilities and health-related quality of life in healthy adults. The results showed that multicomponent cognitive training did not have a significant impact on overall cognition, but there were improvements in some cognitive subtests and quality of life measures that were clinically meaningful.
Background: Cognitive integrity is a fundamental driver of health. The exact structure of strategies against cognitive impairment is still under debate. Objective: To compare the short-term effects of a multicomponent cognitive training (BrainProtect) with those of general health counseling (GHC) on cognitive abilities and health-related quality of life (HRQoL) in healthy adults in Germany. Methods: In this parallel randomized controlled trial (RCT), 132 eligible cognitively healthy adults (age >= 50 years, Beck Depression Inventory <= 9/63; Montreal Cognitive Assessment >= 26/30) were randomized to either GHC (N = 72) or to intervention with BrainProtect (intervention group, IG; N=60). IG participants received 8 weekly sessions of 90 min of the group-based BrainProtect program focusing on executive functions, concentration, learning, perception, and imagination, plus nutritional and physical exercise units. Before and after intervention, all participants underwent neuropsychological testing and HRQoL evaluation, blinded for pretest. Results: No significant training effect was observed for the primary endpoint of global cognition as assessed by CERAD-Plusz Total Score (p = 0.113; eta p(2) = 0.023). Improvements in several cognitive subtests were shown in the IG (N = 53) compared to the GHC (N = 62) without adverse events. Differences reached significance for verbal fluency (p = 0.021), visual memory (p = 0.013), visuo-constructive functions (p = 0.034), and HRQoL (p = 0.009). Significance was lost after adjustment, though several changes were clinically relevant. Conclusion: BrainProtect did not significantly impact global cognition in this RCT. Nevertheless, the results of some outcomes indicate clinically meaningful changes, so that a strengthening of the cognitive performance by BrainProtect cannot be excluded. Further studies with larger sample size are needed to confirm these findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据